KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Net Income (2017 - 2025)

Cardlytics (CDLX) has disclosed Net Income for 9 consecutive years, with -$8.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 47.08% year-over-year to -$8.2 million, compared with a TTM value of -$103.5 million through Dec 2025, up 45.33%, and an annual FY2025 reading of -$103.5 million, up 45.33% over the prior year.
  • Net Income was -$8.2 million for Q4 2025 at Cardlytics, up from -$72.7 million in the prior quarter.
  • Across five years, Net Income topped out at $33.0 million in Q1 2022 and bottomed at -$378.3 million in Q4 2022.
  • Average Net Income over 5 years is -$51.1 million, with a median of -$23.7 million recorded in 2023.
  • Peak annual rise in Net Income hit 232.71% in 2022, while the deepest fall reached 3096.27% in 2022.
  • Year by year, Net Income stood at -$11.8 million in 2021, then crashed by 3096.27% to -$378.3 million in 2022, then soared by 73.34% to -$100.8 million in 2023, then soared by 84.54% to -$15.6 million in 2024, then skyrocketed by 47.08% to -$8.2 million in 2025.
  • Business Quant data shows Net Income for CDLX at -$8.2 million in Q4 2025, -$72.7 million in Q3 2025, and -$9.3 million in Q2 2025.